SAGE Therapeutics Inc at Wolfe Research Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. I hope everyone is having a good second annual Wolfe Healthcare Conference. I know I am. I have the pleasure of hosting Sage's management team, including Steve Kanes, Chief Medical Officer; and Kimi Iguchi, Chief Financial Officer. We are going to dig into, obviously, SAGE-217, but also 718, 324, and also kind of the catalyst path going into next year. I think one thing that stands out to me is you have so many readouts even in the next 6 months that people aren't maybe paying enough attention to.
So I'll leave the floor open to you both if you want to make any opening remarks, and then we'll take it from there. Thank you.
Yes. Well, why don't I kick it off? And thanks, Akash, for having us. This has been a great -- terrific day for us. Steve and I are delighted to be here and delighted to give you an update on Sage. And so we've made a lot of progress this year. So we're
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
